This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirikae, T.
Right arrow Articles by Nakano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirikae, T.
Right arrow Articles by Nakano, M.

 Previous Article  |  Next Article 

Infect Immun, May 1998, p. 1861-1868, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Protective Effects of a Human 18-Kilodalton Cationic Antimicrobial Protein (CAP18)-Derived Peptide against Murine Endotoxemia

Teruo Kirikae,1,* Michimasa Hirata,2 Hiromi Yamasu,1 Fumiko Kirikae,1 Hiroshi Tamura,3 Fumio Kayama,4 Keisuke Nakatsuka,4 Takashi Yokochi,5 and Masayasu Nakano1

Department of Microbiology1 and Department of Environmental Health,4 Jichi Medical School, Minamikawachi-machi, Tochigi-ken 320-0498, Department of Bacteriology, School of Medicine, Iwate Medical University, Morioka 020-8505,2 Tokyo Research Institute, Seikagaku Corporation, Higashiyamato, Tokyo 207-0021,3 and Department of Microbiology and Immunology, Aichi Medical University, Nagakute, Aichi 480-1195,5 Japan

Received 7 July 1997/Returned for modification 5 September 1997/Accepted 2 February 1998

CAP18 (an 18-kDa cationic antimicrobial protein) is a granulocyte-derived protein that can bind lipopolysaccharide (LPS) and inhibit various activities of LPS in vitro. The present study examined the protective effect of a synthetic 27-amino-acid peptide (CAP18109-135) from the LPS-binding domain of CAP18 against antibiotic-induced endotoxin shock, using highly LPS-sensitive D-(+)-galactosamine (D-GalN)-sensitized C3H/HeN mice. The antibiotic-induced endotoxin (CAZ-endotoxin) was prepared from the culture filtrate of Pseudomonas aeruginosa PAO1 exposed to ceftazidime (CAZ). Injection of CAP18109-135 protected the mice injected with LPS or CAZ-endotoxin from death and lowered their tumor necrosis factor (TNF) levels in serum in a dose-dependent manner. Treatment with CAZ caused death of the D-GalN-sensitized P. aeruginosa PAO-infected mice within 48 h, while injection with CAP18109-135 rescued the mice from death. In the mice rescued from death by injection with CAP18109-135, endotoxin levels in plasma and TNF production by liver tissues were decreased but the numbers of viable infecting bacteria in their blood were not decreased significantly and remained at the levels in CAZ-treated mice. These results indicate that CAP18109-135 is capable of preventing antibiotic-induced endotoxic shock in mice with septicemia and that the effect is due to its LPS-neutralizing activity rather than to its antibacterial activity.


* Corresponding author. Mailing address: Department of Microbiology, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi-machi, Tochigi-ken 329-0498, Japan. Phone: 81-285-44-2111, ext. 3162. Fax: 81-285-44-1175. E-mail: tkirikae{at}jichi.ac.jp.


Infect Immun, May 1998, p. 1861-1868, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bjorstad, A., Askarieh, G., Brown, K. L., Christenson, K., Forsman, H., Onnheim, K., Li, H.-N., Teneberg, S., Maier, O., Hoekstra, D., Dahlgren, C., Davidson, D. J., Bylund, J. (2009). The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic Leukocytes. Antimicrob. Agents Chemother. 53: 1027-1038 [Abstract] [Full Text]  
  • Stie, J., Jesaitis, A. V., Lord, C. I., Gripentrog, J. M., Taylor, R. M., Burritt, J. B., Jesaitis, A. J. (2007). Localization of hCAP-18 on the surface of chemoattractant-stimulated human granulocytes: analysis using two novel hCAP-18-specific monoclonal antibodies. J. Leukoc. Biol. 82: 161-172 [Abstract] [Full Text]  
  • Mookherjee, N., Wilson, H. L., Doria, S., Popowych, Y., Falsafi, R., Yu, J., Li, Y., Veatch, S., Roche, F. M., Brown, K. L., Brinkman, F. S. L., Hokamp, K., Potter, A., Babiuk, L. A., Griebel, P. J., Hancock, R. E. W. (2006). Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J. Leukoc. Biol. 80: 1563-1574 [Abstract] [Full Text]  
  • Andra, J., Gutsmann, T., Garidel, P., Brandenburg, K. (2006). Invited review: Mechanisms of endotoxin neutralization by synthetic cationic compounds. Innate Immunity 12: 261-277 [Abstract]  
  • Okuda, D., Yomogida, S., Tamura, H., Nagaoka, I. (2006). Determination of the Antibacterial and Lipopolysaccharide-Neutralizing Regions of Guinea Pig Neutrophil Cathelicidin Peptide CAP11.. Antimicrob. Agents Chemother. 50: 2602-2607 [Abstract] [Full Text]  
  • Nagaoka, I., Tamura, H., Hirata, M. (2006). An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X7.. J. Immunol. 176: 3044-3052 [Abstract] [Full Text]  
  • Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., Powers, J.-P., Bryan, J., Brinkman, F. S. L., Hancock, R. E. W. (2006). Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37. J. Immunol. 176: 2455-2464 [Abstract] [Full Text]  
  • Bowdish, D. M.E., Hancock, R. E.W. (2005). Anti-endotoxin properties of cationic host defence peptides and proteins. Innate Immunity 11: 230-236 [Abstract]  
  • Gombart, A. F., Borregaard, N., Koeffler, H. P. (2005). Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19: 1067-1077 [Abstract] [Full Text]  
  • Kurosaka, K., Chen, Q., Yarovinsky, F., Oppenheim, J. J., Yang, D. (2005). Mouse Cathelin-Related Antimicrobial Peptide Chemoattracts Leukocytes Using Formyl Peptide Receptor-Like 1/Mouse Formyl Peptide Receptor-Like 2 as the Receptor and Acts as an Immune Adjuvant. J. Immunol. 174: 6257-6265 [Abstract] [Full Text]  
  • Silverstein, R. (2004). Review: D-Galactosamine lethality model: scope and limitations. Innate Immunity 10: 147-162 [Abstract]  
  • Bowdish, D. M. E., Davidson, D. J., Speert, D. P., Hancock, R. E. W. (2004). The Human Cationic Peptide LL-37 Induces Activation of the Extracellular Signal-Regulated Kinase and p38 Kinase Pathways in Primary Human Monocytes. J. Immunol. 172: 3758-3765 [Abstract] [Full Text]  
  • Zanetti, M. (2004). Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75: 39-48 [Abstract] [Full Text]  
  • Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]  
  • Sallenave, J.-M., Cunningham, G. A., James, R. M., McLachlan, G., Haslett, C. (2003). Regulation of Pulmonary and Systemic Bacterial Lipopolysaccharide Responses in Transgenic Mice Expressing Human Elafin. Infect. Immun. 71: 3766-3774 [Abstract] [Full Text]  
  • Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., Tanaka, S., Heumann, D. (2002). Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement with Hydrophobic and Cationic Amino Acid Residues. CVI 9: 972-982 [Abstract] [Full Text]  
  • Hase, K., Eckmann, L., Leopard, J. D., Varki, N., Kagnoff, M. F. (2002). Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium. Infect. Immun. 70: 953-063 [Abstract] [Full Text]  
  • Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., Heumann, D. (2001). Cathelicidin Family of Antibacterial Peptides CAP18 and CAP11 Inhibit the Expression of TNF-{alpha} by Blocking the Binding of LPS to CD14+ Cells. J. Immunol. 167: 3329-3338 [Abstract] [Full Text]  
  • Yang, D., Chertov, O., Oppenheim, J. J. (2001). Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 69: 691-697 [Abstract] [Full Text]  
  • Hancock, R. E. W., Scott, M. G. (2000). The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 97: 8856-8861 [Abstract] [Full Text]  
  • Silverstein, R., Wood, J. G., Xue, Q., Norimatsu, M., Horn, D. L., Morrison, D. C. (2000). Differential Host Inflammatory Responses to Viable Versus Antibiotic-Killed Bacteria in Experimental Microbial Sepsis. Infect. Immun. 68: 2301-2308 [Abstract] [Full Text]  
  • SWIERZKO, A. S., KIRIKAE, T., KIRIKAE, F., HIRATA, M., CEDZYNSKI, M., ZIOLKOWSKI, A., HIRAI, Y., KUSUMOTO, S., YOKOCHI, T., NAKANO, M. (2000). Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide. J Med Microbiol 49: 127-138 [Abstract] [Full Text]  
  • Scott, M. G., Vreugdenhil, A. C. E., Buurman, W. A., Hancock, R. E. W., Gold, M. R. (2000). Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein. J. Immunol. 164: 549-553 [Abstract] [Full Text]  
  • Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., Wilson, J. M. (1999). Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide. Infect. Immun. 67: 6084-6089 [Abstract] [Full Text]  
  • Sawa, T., Kurahashi, K., Ohara, M., Gropper, M. A., Doshi, V., Larrick, J. W., Wiener-Kronish, J. P. (1998). Evaluation of Antimicrobial and Lipopolysaccharide-Neutralizing Effects of a Synthetic CAP18 Fragment against Pseudomonas aeruginosa in a Mouse Model. Antimicrob. Agents Chemother. 42: 3269-3275 [Abstract] [Full Text]